ex vivo cochlear explants

Cilcare is a biotech founded in 2014 dedicated to auditory sciences, supporting partners in the health and life-sciences sector in developing therapies to prevent and treat auditory-related diseases such as inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. It offers ex vivo and in vivo pharmacological models, GLP toxicology for ototoxicity, and operates from France and the US.

Read more

behavioral testingbioanalysiscochlear implantationelectrophysiology (ABR, DPOAE)formulation for otic deliveryGLP toxicologyhistopathologyinner ear deliveryin vitro assaysin vivo modelsmicrosurgerypharmacokinetics